For example, genetic variants associated with downregulated surface expression of triggering receptor expressed on myeloid cells, resulting in less binding of the triggering receptor expressed on myeloid cells ligands,3 and genetic variants associated with increased expression of CD33,5 both negatively affecting the phagocytic and Aβ clearance capacity, were associated with high risk of AD. Here, CD33 is linked to Alzheimer disease.